Aclaris Therapeutics (ACRS) Shares Outstanding (Diluted) (2019 - 2026)
Aclaris Therapeutics' Weighted Average Shares Outstanding (Diluted) came in at 142.74 million for Q2 2026, up 16.4% from 122.58 million a year earlier and up 10.8% from the prior quarter.
Powered by 
Analysis
Aclaris Therapeutics (ACRS) Shares Outstanding (Diluted) (2019 - 2026) Analysis & Trends
For FY2025, Aclaris Therapeutics' Weighted Average Shares Outstanding (Diluted) was 122.56 million, up 58.6% from FY2024.
- Weighted Average Shares Outstanding (Diluted) has increased in each of the last six years, with a five-year compound annual growth rate of 23.6% (FY2020 to FY2025).
- Going back by year, Weighted Average Shares Outstanding (Diluted) was 77.3 million in FY2024 (+10.7%), 69.81 million in FY2023 (+7.0%), 65.21 million in FY2022 (+15.0%) and 56.73 million in FY2021 (+33.4%).
- The Q2 2026 figure represents the highest quarterly Weighted Average Shares Outstanding (Diluted) in data going back to Q4 2019.
- Year-over-year, Weighted Average Shares Outstanding (Diluted) has increased for 23 consecutive quarters, with growth averaging 38.5% over the last eight quarters.
- The year-over-year growth in Weighted Average Shares Outstanding (Diluted) has ranged between 0.8% (Q3 2024) and 72.2% (Q1 2025) over the last five years.
- Business Quant data shows ACRS's Weighted Average Shares Outstanding (Diluted) at 128.81 million (Q1 2026), 122.56 million (Q4 2025) and 122.62 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 893.40 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 2.45 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 1.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 2.48 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 1.96 Bn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 1.56 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 546.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.25 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 5.75 Bn |
| 10 | Aclaris Therapeutics | 625.92 Mn | 223.91 Mn | 1.29 Mn | 149.45 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 149.45 Mn |
| Jun 30, 2026 | 142.74 Mn |
| Mar 31, 2026 | 128.81 Mn |
| Dec 31, 2025 | 122.56 Mn |
| Sep 30, 2025 | 122.62 Mn |
| Jun 30, 2025 | 122.58 Mn |
| Mar 31, 2025 | 122.39 Mn |
| Dec 31, 2024 | 77.30 Mn |
| Sep 30, 2024 | 71.38 Mn |
| Jun 30, 2024 | 71.29 Mn |
| Mar 31, 2024 | 71.07 Mn |
| Dec 31, 2023 | 69.81 Mn |
| Sep 30, 2023 | 70.81 Mn |
| Jun 30, 2023 | 70.63 Mn |
| Mar 31, 2023 | 66.87 Mn |
| Dec 31, 2022 | 65.21 Mn |
| Sep 30, 2022 | 66.68 Mn |
| Jun 30, 2022 | 65.99 Mn |
| Mar 31, 2022 | 61.43 Mn |
| Dec 31, 2021 | 56.73 Mn |
API Access
Aclaris Therapeutics Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=ACRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "ACRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=ACRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();